GW Pharma CEO talks Epidiolex sales, potential CBD treatment for PTSD

GW Pharmaceutical CEO Justin Gover tells "Mad Money" host Jim Cramer the company sold $300 million worth of its CBD-based epilepsy drug in 2019 and other treatments in the pipeline.
08:50
Thu, Jan 16 20207:16 PM EST